Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital-Reference-Cited by-同舟云学术

Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital

Published:2005-01 Issue:5 Volume:34 Page:353-358
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Wick M. C.,Ernestam S.,Lindblad S.,Bratt J.,Klareskog L.,van Vollenhoven R. F.

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03009740510026887

Reference20 articles.

1. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

2. Rheumatoid Arthritis—A Molecular Understanding

3. New Drugs for Rheumatoid Arthritis

4. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?;JCR: Journal of Clinical Rheumatology;2023-08-24

2. Primary and secondary non-response: in need of operational definitions in observational studies;Annals of the Rheumatic Diseases;2021-04-21

3. Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis;Therapeutic Advances in Musculoskeletal Disease;2021-01

4. Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis;Expert Opinion on Drug Discovery;2020-11-18

5. Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus;Rheumatology;2018-10-01